Contents

Current Cancer Drug Targets, Volume 15 - Number 1


Novel Synthetic Pharmacophores Inducing a Stabilization of Cellular Microtubules

, 15(1): 2 - 13

Anne Martinez, Emmanuelle Soleilhac, Caroline Barette, Renaud Prudent, Gustavo J. Gozzi, Emilie Vassal-Stermann, Catherine Pillet, Attilio Di Pietro, Marie-Odile Fauvarque and Laurence Lafanechere


DOI: 10.2174/1568009615666141215154149



Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways

, 15(1): 14 - 26

Rahul Kumar, Gagan Deep, Michael F. Wempe, Rajesh Agarwal and Chapla Agarwal


DOI: 10.2174/1568009614666141229102254



Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy

, 15(1): 27 - 34

Changpeng Zhu, Meng Ji, Weiping Dai, Changhong Ye, Zhiqian Hu, Jian Shi, Xin Zeng and Yong Lin


DOI: 10.2174/1568009615666150101115800



Potential Anti-cancer Drugs Commonly Used for Other Indications

, 15(1): 35 - 52

Veronika Hanusova, Lenka Skalova, Vera Kralova and Petra Matouskova


DOI: 10.2174/1568009615666141229152812



MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies

, 15(1): 53 - 70

Xin Li, Xin A. Zhang, Wei Xie, Xiaoqing Li and Shiang Huang


DOI: 10.2174/1568009615666150105120055



Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer

, 15(1): 71 - 86

Sams M.A. Sadat, Soodabeh Saeidnia, Adil J. Nazarali and Azita Haddadi


DOI: 10.2174/1568009615666150105115047




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science